Prediction/NN
of/IN
Quantitative/JJ
Traits/NNS
Using/VBG
Common/JJ
Genetic/JJ
Variants/NNS
:/:
Application/NN
to/TO
Body/NN
Mass/NN
Index/NN
./.
====================
With/IN
the/DT
success/NN
of/IN
the/DT
genome-wide/NN
association/NN
studies/NNS
(/(
GWASs/NNS
)/)
,/,
many/JJ
candidate/NN
loci/NNS
for/IN
complex/NN
human/JJ
diseases/NNS
have/VBP
been/VBN
reported/VBN
in/IN
the/DT
GWAS/NN
catalog/NN
./.
====================
Recently/RB
,/,
many/JJ
disease/NN
prediction/NN
models/NNS
based/VBN
on/IN
penalized/VBN
regression/NN
or/CC
statistical/JJ
learning/VBG
methods/NNS
were/VBD
proposed/VBN
using/VBG
candidate/NN
causal/JJ
variants/NNS
from/IN
significant/JJ
single-nucleotide/JJ
polymorphisms/NNS
of/IN
GWASs/NNS
./.
====================
However/RB
,/,
there/EX
have/VBP
been/VBN
only/RB
a/DT
few/JJ
systematic/JJ
studies/NNS
comparing/VBG
existing/VBG
methods/NNS
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
first/RB
constructed/VBN
risk/NN
prediction/NN
models/NNS
,/,
such/JJ
as/IN
stepwise/RB
linear/JJ
regression/NN
(/(
SLR/NN
)/)
,/,
least/JJS
absolute/JJ
shrinkage/NN
and/CC
selection/NN
operator/NN
(/(
LASSO/NN
)/)
,/,
and/CC
Elastic-Net/NN
(/(
EN/NN
)/)
,/,
using/VBG
a/DT
GWAS/JJ
chip/NN
and/CC
GWAS/NN
catalog/NN
./.
====================
We/PRP
then/RB
compared/VBD
the/DT
prediction/NN
accuracy/NN
by/IN
calculating/VBG
the/DT
mean/JJ
square/VBP
error/NN
(/(
MSE/NN
)/)
value/NN
on/IN
data/NNS
from/IN
the/DT
Korea/NN
Association/NN
Resource/NN
(/(
KARE/NN
)/)
with/IN
body/NN
mass/NN
index/NN
./.
====================
Our/PRP$
results/NNS
show/VBP
that/IN
SLR/NN
provides/VBZ
a/DT
smaller/JJR
MSE/NN
value/NN
than/IN
the/DT
other/JJ
methods/NNS
,/,
while/IN
the/DT
numbers/NNS
of/IN
selected/VBN
variables/NNS
in/IN
each/DT
model/NN
were/VBD
similar/JJ
./.
====================
With/IN
the/DT
development/NN
of/IN
genotyping/VBG
technologies/NNS
,/,
many/JJ
disease-related/JJ
genetic/JJ
variants/NNS
have/VBP
been/VBN
verified/VBN
by/IN
genome-wide/NN
association/NN
studies/NNS
(/(
GWASs/NNS
)/)
./.
====================
Diagnosis/NN
and/CC
disease/NN
risk/NN
prediction/NN
from/IN
the/DT
utilization/NN
of/IN
the/DT
genetic/JJ
variants/NNS
have/VBP
improved/VBN
even/RB
further/RBR
[/(
1/CD
]/)
./.
====================
Direct-to-consumer/NN
genetic/JJ
companies/NNS
,/,
such/JJ
as/IN
23andME/JJ
(/(
http/NN
:/:
//www.23andme.com//JJ
)/)
and/CC
Pathway/NN
Genomics/NNS
(/(
https/NNS
:/:
//www.pathway.com//JJ
)/)
,/,
provide/VBP
personal/JJ
genome/NN
information/NN
services/VBZ
./.
====================
For/IN
example/NN
,/,
the/DT
BRCA1/NN
and/CC
BRCA2/NN
genes/NNS
play/VBP
important/JJ
roles/NNS
in/IN
breast/NN
cancer/NN
diagnosis/NN
and/CC
clinical/JJ
treatment/NN
[/(
23/CD
]/)
./.
====================
While/IN
several/JJ
disease/NN
prediction/NN
studies/NNS
have/VBP
been/VBN
conducted/VBN
using/VBG
disease-related/JJ
genetic/JJ
variants/NNS
,/,
there/EX
are/VBP
some/DT
limitations/NNS
to/TO
disease/NN
risk/NN
prediction/NN
./.
====================
It/PRP
becomes/VBZ
difficult/JJ
to/TO
construct/VB
a/DT
disease/NN
risk/NN
prediction/NN
model/NN
,/,
because/IN
there/EX
are/VBP
typically/RB
a/DT
larger/RBR
number/NN
of/IN
genetic/JJ
variants/NNS
than/IN
the/DT
number/NN
of/IN
individuals/NNS
in/IN
the/DT
“/NN
large/JJ
p/NN
small/JJ
n/NN
”/CD
problem/NN
./.
====================
Also/RB
,/,
the/DT
effect/NN
size/NN
of/IN
genetic/JJ
variants/NNS
for/IN
most/JJS
complex/NN
human/JJ
diseases/NNS
is/VBZ
small/JJ
,/,
and/CC
missing/JJ
heritability/NN
exists/VBZ
[/(
4/CD
]/)
./.
====================
Moreover/RB
,/,
some/DT
loss/NN
of/IN
statistical/JJ
power/JJR
to/TO
identify/VB
significant/JJ
associations/NNS
is/VBZ
caused/VBN
by/IN
the/DT
correlating/VBG
single-nucleotide/JJ
polymorphisms/NNS
(/(
SNPs/NNS
)/)
due/JJ
to/TO
linkage/NN
disequilibrium/NN
(/(
LD/NN
)/)
[/(
5/CD
]/)
./.
====================
Multicollinearity/JJ
due/JJ
to/TO
high/JJ
LD/NN
among/IN
SNPs/NNS
causes/VBZ
high/JJ
variance/NN
of/IN
coefficient/JJ
estimates/NNS
./.
====================
In/IN
order/NN
to/TO
solve/VB
these/DT
issues/NNS
,/,
various/JJ
statistical/JJ
approaches/NNS
have/VBP
been/VBN
recently/RB
proposed/VBN
./.
====================
Initially/RB
,/,
a/DT
gene/NN
score/VBP
(/(
GS/NN
)/)
was/VBD
computed/VBN
using/VBG
statistical/JJ
models/NNS
for/IN
disease/NN
risk/NN
prediction/NN
[/(
678/CD
]/)
./.
====================
These/DT
risk/NN
prediction/NN
models/NNS
were/VBD
created/VBN
from/IN
GSs/NN
by/IN
summing/VBG
up/IN
the/DT
marginal/JJ
effect/NN
of/IN
each/DT
disease-associated/JJ
genetic/JJ
variant/NN
./.
====================
Several/JJ
studies/NNS
have/VBP
shown/VBN
that/IN
GS/NN
is/VBZ
useful/JJ
for/IN
risk/NN
prediction/NN
[/(
9/CD
]/)
./.
====================
However/RB
,/,
the/DT
accuracy/NN
of/IN
the/DT
risk/NN
prediction/NN
is/VBZ
poor/JJ
when/WRB
joint/NN
effects/NNS
exist/VBP
between/IN
multiple/JJ
genetic/JJ
variants/NNS
[/(
1011/CD
]/)
./.
====================
Building/VBG
a/DT
risk/NN
prediction/NN
model/NN
using/VBG
multiple/JJ
SNPs/NNS
is/VBZ
an/DT
effective/JJ
way/NN
to/TO
improve/VB
disease/NN
risk/NN
prediction/NN
./.
====================
Multiple/JJ
logistic/JJ
regression/NN
(/(
MLR/NN
)/)
is/VBZ
one/CD
of/IN
the/DT
typical/JJ
traditional/JJ
approaches/NNS
./.
====================
Several/JJ
studies/NNS
have/VBP
shown/VBN
the/DT
usefulness/NN
of/IN
an/DT
MLR-based/JJ
approach/NN
for/IN
creating/VBG
disease/NN
risk/NN
prediction/NN
models/NNS
[/(
121314/CD
]/)
./.
====================
However/RB
,/,
the/DT
parameter/NN
estimation/NN
of/IN
MLR/NN
becomes/VBZ
unstable/JJ
,/,
and/CC
the/DT
predictive/JJ
power/JJR
of/IN
the/DT
risk/NN
prediction/NN
model/NN
decreases/VBZ
if/IN
there/EX
is/VBZ
high/JJ
LD/NN
among/IN
SNPs/NNS
./.
====================
In/IN
order/NN
to/TO
solve/VB
the/DT
“/NN
large/JJ
p/NN
and/CC
small/JJ
n/NN
”/JJ
problem/NN
,/,
many/JJ
penalized/JJ
regression/NN
approaches/NNS
,/,
like/IN
ridge/NN
[/(
151617/CD
]/)
,/,
least/JJS
absolute/JJ
shrinkage/NN
and/CC
selection/NN
operator/NN
(/(
LASSO/NN
)/)
[/(
18/CD
]/)
,/,
and/CC
Elastic-Net/NN
(/(
EN/NN
)/)
[/(
19/CD
]/)
,/,
have/VBP
been/VBN
proposed/VBN
./.
====================
For/IN
highdimensional/JJ
data/NNS
,/,
these/DT
penalized/VBN
approaches/NNS
have/VBP
several/JJ
advantages/NNS
in/IN
variable/JJ
selection/NN
,/,
as/IN
well/RB
as/IN
in/IN
prediction/NN
,/,
over/IN
non-penalized/JJ
approaches/NNS
./.
====================
For/IN
example/NN
,/,
several/JJ
researchers/NNS
showed/VBD
that/IN
the/DT
utilization/NN
of/IN
a/DT
large/JJ
amount/NN
of/IN
SNPs/NNS
with/IN
penalized/VBN
regression/NN
approaches/NNS
improves/VBZ
the/DT
accuracy/NN
of/IN
Crohn/NN
's/POS
disease/NN
and/CC
bipolar/JJ
disorder/NN
risk/NN
prediction/NN
[/(
2021/CD
]/)
./.
====================
It/PRP
is/VBZ
important/JJ
to/TO
build/JJ
a/DT
risk/NN
prediction/NN
model/NN
that/DT
pertains/NNS
to/TO
discrete/JJ
variables/NNS
,/,
such/JJ
as/IN
disease/NN
diagnosis/NN
./.
====================
It/PRP
is/VBZ
also/RB
important/JJ
to/TO
make/VB
predictions/NNS
based/VBN
on/IN
continuous/JJ
variables/NNS
,/,
such/JJ
as/IN
human/JJ
health-related/JJ
outcomes/NNS
./.
====================
When/WRB
using/VBG
medicines/NNS
to/TO
treat/VB
diseases/NNS
,/,
we/PRP
can/MD
use/VB
genetic/JJ
information/NN
to/TO
calculate/JJ
the/DT
dosage/JJ
,/,
in/IN
addition/NN
to/TO
basic/JJ
physical/JJ
information/NN
,/,
such/JJ
as/IN
height/RB
and/CC
weight/NN
./.
====================
For/IN
example/NN
,/,
there/EX
is/VBZ
a/DT
prediction/NN
model/NN
for/IN
warfarin/NN
responsiveness/NN
that/IN
was/VBD
made/VBN
with/IN
multivariate/JJ
linear/JJ
regression/NN
[/(
22/CD
]/)
./.
====================
We/PRP
can/MD
apply/RB
such/JJ
a/DT
model/NN
directly/RB
to/TO
disease/NN
treatment/NN
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
focus/VBP
on/IN
the/DT
prediction/NN
of/IN
quantitative/JJ
traits/VBZ
using/VBG
common/JJ
genetic/JJ
variants/NNS
./.
====================
We/PRP
systematically/RB
compared/VBN
the/DT
performance/NN
of/IN
prediction/NN
models/NNS
through/IN
real/JJ
data/NNS
from/IN
the/DT
Korea/NN
Association/NN
Resource/NN
(/(
KARE/NN
)/)
./.
====================
We/PRP
first/RB
selected/VBN
the/DT
prediction/NN
variables/NNS
using/VBG
statistical/JJ
methods/NNS
,/,
such/JJ
as/IN
stepwise/JJ
linear/JJ
regression/NN
(/(
SLR/NN
)/)
,/,
LASSO/NN
,/,
and/CC
EN/NN
./.
====================
We/PRP
then/RB
constructed/VBD
commonly/RB
used/VBN
risk/NN
prediction/NN
models/NNS
,/,
such/JJ
as/IN
SLR/NN
,/,
LASSO/NN
,/,
and/CC
EN/NN
./.
====================
Finally/RB
,/,
we/PRP
compared/VBD
the/DT
predictive/JJ
accuracy/NN
by/IN
calculating/VBG
the/DT
mean/JJ
square/VBP
error/NN
(/(
MSE/NN
)/)
value/NN
for/IN
predicting/VBG
body/NN
mass/NN
index/NN
(/(
BMI/NN
)/)
./.
====================
Overall/RB
,/,
our/PRP$
results/NNS
show/VBP
that/IN
LASSO/NN
and/CC
SLR/NN
provide/VBP
the/DT
smallest/JJS
MSE/NN
value/NN
among/IN
the/DT
compared/VBN
methods/NNS
./.
====================
Data/NNS
====================
The/DT
KARE/NN
project/NN
,/,
which/WDT
began/VBD
in/IN
2007/CD
,/,
is/VBZ
an/DT
Anseong/JJ
and/CC
Ansan/NN
regional/JJ
society-based/VBN
cohort/NN
./.
====================
After/IN
applying/VBG
SNP/NN
quality/NN
control/NN
criteria—Hardy-Weinberg/JJ
equilibrium/NN
p/NN
</JJR
10−06/CD
,/,
genotype/NN
call/JJ
rates/NNS
</JJR
95/CD
%/NN
,/,
and/CC
minor/JJ
allele/NN
frequency/NN
</JJR
0.01—352,228/CD
SNPs/NNS
were/VBD
utilized/VBN
for/IN
analysis/NN
./.
====================
Also/RB
,/,
after/IN
eliminating/VBG
401/CD
samples/NNS
with/IN
call/JJ
rates/NNS
less/RBR
than/IN
96/CD
%/NN
,/,
11/CD
contaminated/JJ
samples/NNS
,/,
41/CD
gender-inconsistent/JJ
samples/NNS
,/,
101/CD
serious/JJ
concomitant/JJ
illness/NN
samples/NNS
,/,
608/CD
cryptic-related/JJ
samples/NNS
,/,
and/CC
4/CD
samples/NNS
with/IN
missing/JJ
phenotype/NN
,/,
8,838/CD
participants/NNS
were/VBD
analyzed/VBN
[/(
23/CD
]/)
./.
====================
Table/JJ
1/CD
summarizes/VBZ
the/DT
demographic/JJ
information/NN
./.
====================
In/IN
addition/NN
,/,
Fig/NN
./.
====================
1/CD
shows/VBZ
box/NN
plots/NNS
of/IN
BMI/NN
for/IN
the/DT
given/VBN
demographic/JJ
variables/NNS
./.
====================
Statistical/JJ
analysis/NN
====================
We/PRP
selected/VBD
SNPs/NNS
from/IN
the/DT
KARE/NN
data/NNS
analysis/NN
based/VBN
on/IN
single-SNP/JJ
analysis/NN
and/CC
collected/JJ
SNPs/NNS
in/IN
the/DT
GWAS/NN
catalog/NN
[/(
24/CD
]/)
./.
====================
Then/RB
,/,
we/PRP
performed/VBD
two/CD
steps/NNS
to/TO
make/VB
quantitative/JJ
prediction/NN
models/NNS
./.
====================
First/RB
,/,
we/PRP
selected/VBD
the/DT
variables/NNS
by/IN
using/VBG
SLR/NN
,/,
LASSO/NN
,/,
and/CC
EN/NN
and/CC
then/RB
built/VBP
quantitative/JJ
prediction/NN
models/NNS
by/IN
using/VBG
the/DT
same/JJ
methods/NNS
./.
====================
SNP/NN
sets/NNS
====================
First/RB
,/,
based/VBN
on/IN
three/CD
different/JJ
populations—overall/NN
population/NN
,/,
Asian-only/RB
population/NN
,/,
and/CC
Korean-only/RB
population/NN
—we/PRP
collected/JJ
the/DT
SNPs/NNS
registered/VBD
in/IN
the/DT
GWAS/NN
catalog/NN
for/IN
BMI/NN
./.
====================
Second/RB
,/,
the/DT
SNPs/NNS
were/VBD
selected/VBN
by/IN
single-SNP/JJ
analysis/NN
using/VBG
linear/JJ
regression/NN
with/IN
adjustments/NNS
for/IN
sex/NN
,/,
age/NN
,/,
and/CC
area/NN
./.
====================
We/PRP
chose/VBP
the/DT
SNPs/NNS
based/VBN
on/IN
the/DT
p-values/NNS
./.
====================
We/PRP
considered/VBD
the/DT
following/VBG
seven/CD
SNP/NN
sets/NNS
:/:
====================
(/(
1/CD
)/)
ASIAN-100/NN
(/(
GWAS/NN
catalog/NN
[/(
Asia/NN
]/)
+/JJ
Single-SNP/NN
analysis/NN
,/,
number/NN
of/IN
SNPs/NNS
=/JJ
100/CD
)/)
====================
(/(
2/CD
)/)
KOREAN-100/NN
(/(
GWAS/NN
catalog/NN
[/(
Korea/NN
]/)
+/JJ
single-SNP/NN
analysis/NN
,/,
number/NN
of/IN
SNPs/NNS
=/JJ
100/CD
)/)
====================
(/(
3/CD
)/)
ALL-200/CD
(/(
GWAS/NN
catalog/NN
[/(
All/DT
]/)
+/JJ
single-SNP/NN
analysis/NN
,/,
number/NN
of/IN
SNPs/NNS
=/JJ
200/CD
)/)
====================
(/(
4/CD
)/)
ASIAN-200/CD
(/(
GWAS/NN
catalog/NN
[/(
Asia/NN
]/)
+/JJ
single-SNP/NN
analysis/NN
,/,
number/NN
of/IN
SNPs/NNS
=/JJ
200/CD
)/)
====================
(/(
5/CD
)/)
KOREAN-200/CD
(/(
GWAS/NN
catalog/NN
[/(
Korea/NN
]/)
+/JJ
single-SNP/NN
analysis/NN
,/,
number/NN
of/IN
SNPs/NNS
=/JJ
200/CD
)/)
====================
(/(
6/CD
)/)
GWAS-ALL/NN
(/(
GWAS/NN
catalog/NN
[/(
All/DT
]/)
,/,
number/NN
of/IN
SNPs/NNS
=/JJ
136/CD
)/)
====================
(/(
7/CD
)/)
GWAS-ASIAN/NN
(/(
GWAS/NN
catalog/NN
[/(
Asia/NN
]/)
,/,
number/NN
of/IN
SNPs/NNS
=/JJ
16/CD
)/)
====================
Step/JJ
1/CD
:/:
Variable/JJ
selection/NN
====================
In/IN
the/DT
KARE/NN
data/NNS
,/,
out/RP
of/IN
8,838/CD
individuals/NNS
,/,
we/PRP
randomly/RB
selected/VBN
1,767/CD
for/IN
test/NN
sets/NNS
and/CC
composed/VBN
the/DT
training/VBG
set/NN
with/IN
the/DT
rest/JJS
of/IN
the/DT
7,071/CD
participants/NNS
./.
====================
We/PRP
selected/VBD
SNPs/NNS
using/VBG
5-fold/JJ
cross-validation/NN
(/(
CV/NN
)/)
of/IN
the/DT
training/VBG
set/NN
./.
====================
In/IN
this/DT
case/NN
,/,
we/PRP
used/VBD
SLR/NN
,/,
LASSO/NN
,/,
and/CC
EN/NN
to/TO
select/VB
SNPs/NNS
./.
====================
The/DT
SLR/NN
model/NN
is/VBZ
one/CD
of/IN
the/DT
most/JJS
widely/RB
used/VBN
models/NNS
./.
====================
Let/NNP
yi/RB
be/VB
a/DT
quantitative/JJ
phenotype/NN
for/IN
subject/JJ
i/LS
=/JJ
1/CD
,/,
…/NNP
,/,
n/NN
;/:
xij/RB
be/VB
the/DT
value/NN
of/IN
SNP/NN
j/RB
=/JJ
1/CD
,/,
…/NNP
,/,
p/NN
for/IN
subject/JJ
i/LS
;/:
code/VBP
be/VB
0/CD
,/,
1/CD
,/,
and/CC
2/CD
for/IN
the/DT
number/NN
of/IN
minor/JJ
alleles/NNS
;/:
and/CC
εi/FW
be/VB
the/DT
error/JJ
term/NN
for/IN
subject/JJ
i/LS
./.
====================
The/DT
SLR/NN
model/NN
is/VBZ
yi/RB
=/JJ
β0/CD
+/JJ
β1xi1/NN
+/JJ
.../:
+/JJ
βpxip/NN
+/JJ
γ1sexi/NNS
+/JJ
γ2agei/NNS
+/JJ
γ3areai/NNS
+/JJ
εi/NNS
,/,
where/WRB
β0/CD
and/CC
βj/FW
are/VBP
the/DT
intercept/NN
and/CC
effect/NN
sizes/NNS
of/IN
SNPs/NNS
,/,
respectively/RB
./.
====================
γ1/RB
,/,
γ2/NN
,/,
and/CC
γ3/NN
represent/VBP
the/DT
sex/NN
,/,
age/NN
,/,
and/CC
area/NN
of/IN
the/DT
i-th/NN
individual/JJ
,/,
respectively/RB
./.
====================
Variable/JJ
selection/NN
was/VBD
performed/VBN
by/IN
a/DT
MSE-based/JJ
stepwise/JJ
procedure/NN
./.
====================
The/DT
stepwise/JJ
procedure/NN
was/VBD
performed/VBN
using/VBG
the/DT
R/NN
package/NN
“/CD
MASS/NN
”/CD
[/(
25/CD
]/)
./.
====================
The/DT
LASSO/NN
and/CC
EN/NN
estimates/NNS
of/IN
β/JJ
were/VBD
obtained/VBN
by/IN
minimizing/VBG
∑i=1nyi-β0-β1χ1i-…-βpχpi-γ1sexi-γ2agei-γ3areai2+λ1∑j=1p|βj|/NN
and/CC
∑i=1nyi-β0-β1χ1i-…-βpχpi-γ1sexi-γ2agei-γ3areai2+λ1∑j=1p|βj|+λ2∑j=1pβj2/NN
,/,
respectively/RB
./.
====================
The/DT
tuning/JJ
parameters/NNS
λ1/NN
and/CC
λ2/NN
are/VBP
estimated/VBN
using/VBG
CV/NN
./.
====================
The/DT
penalized/VBN
methods/NNS
were/VBD
performed/VBN
using/VBG
the/DT
R/NN
package/NN
“/CD
glmnet/NN
”/CD
[/(
26/CD
]/)
./.
====================
Then/RB
,/,
we/PRP
defined/VBD
five/CD
groups/NNS
./.
====================
(/(
1/CD
)/)
Group/NN
1/CD
(/(
consists/VBZ
of/IN
SNPs/NNS
that/DT
appeared/VBD
at/IN
least/JJS
one/CD
time/NN
in/IN
the/DT
5-fold/JJ
CV/NN
)/)
====================
(/(
2/CD
)/)
Group/NN
2/CD
(/(
consists/VBZ
of/IN
the/DT
SNPs/NNS
that/DT
appeared/VBD
at/IN
least/JJS
two/CD
times/NNS
in/IN
the/DT
5-fold/JJ
CV/NN
)/)
====================
(/(
3/CD
)/)
Group/NN
3/CD
(/(
consists/VBZ
of/IN
the/DT
SNPs/NNS
that/DT
appeared/VBD
at/IN
least/JJS
three/CD
times/NNS
in/IN
the/DT
5-fold/JJ
CV/NN
)/)
====================
(/(
4/CD
)/)
Group/NN
4/CD
(/(
consists/VBZ
of/IN
the/DT
SNPs/NNS
that/DT
appeared/VBD
at/IN
least/JJS
four/CD
times/NNS
in/IN
the/DT
5-fold/JJ
CV/NN
)/)
====================
(/(
5/CD
)/)
Group/NN
5/CD
(/(
consists/VBZ
of/IN
the/DT
SNPs/NNS
that/DT
appeared/VBD
in/IN
all/DT
5-fold/JJ
CVs/NNS
)/)
====================
Step/JJ
2/CD
:/:
Quantitative/JJ
prediction/NN
====================
To/TO
build/JJ
a/DT
quantitative/JJ
prediction/NN
model/NN
,/,
we/PRP
used/VBD
the/DT
same/JJ
prediction/NN
methods/NNS
that/DT
were/VBD
applied/VBN
for/IN
the/DT
variable/JJ
selection/NN
step/NN
for/IN
the/DT
comparison/NN
of/IN
these/DT
three/CD
methods/NNS
in/IN
the/DT
variable/JJ
selection/NN
and/CC
quantitative/JJ
prediction/NN
./.
====================
Each/DT
prediction/NN
model/NN
was/VBD
created/VBN
by/IN
using/VBG
7,071/CD
training/VBG
individuals/NNS
via/IN
5-fold/JJ
CV/NN
./.
====================
To/TO
compare/VB
the/DT
performance/NN
of/IN
the/DT
quantitative/JJ
prediction/NN
models/NNS
,/,
we/PRP
calculated/VBD
the/DT
MSE/NN
by/IN
applying/VBG
each/DT
quantitative/JJ
prediction/NN
model/NN
using/VBG
the/DT
test/NN
set/NN
(/(
n/NN
=/JJ
1,767/CD
)/)
./.
====================
To/TO
create/VB
the/DT
SNP/NN
sets/NNS
associated/VBN
with/IN
BMI/NN
,/,
single-SNP/JJ
analysis/NN
was/VBD
performed/VBN
by/IN
linear/JJ
regression/NN
with/IN
adjustments/NNS
for/IN
sex/NN
,/,
age/NN
,/,
and/CC
area/NN
./.
====================
As/IN
shown/VBN
in/IN
Supplementary/JJ
Fig/NN
./.
====================
1/CD
,/,
we/PRP
found/VBD
one/CD
significant/JJ
SNP/NN
(/(
rs17178527/NN
)/)
after/IN
Bonferroni/NNP
correction/NN
(/(
1.45/CD
×/CD
10−07/CD
)/)
./.
====================
rs17178527/NN
of/IN
LOC729076/NN
has/VBZ
been/VBN
reported/VBN
as/IN
BMI-associated/JJ
SNP/NN
in/IN
previous/JJ
GWASs/NNS
[/(
2327/CD
]/)
./.
====================
In/IN
addition/NN
,/,
Supplementary/JJ
Table/JJ
1/CD
shows/VBZ
the/DT
results/NNS
of/IN
the/DT
single-SNP/JJ
analysis/NN
with/IN
p-values/NNS
less/RBR
than/IN
5.00/CD
×/CD
10−05/CD
./.
====================
The/DT
SNPs/NNS
that/DT
were/VBD
reported/VBN
to/TO
be/VB
associated/VBN
with/IN
BMI/NN
in/IN
the/DT
GWAS/NN
catalog/NN
are/VBP
summarized/VBN
in/IN
Supplementary/JJ
Table/JJ
2/CD
./.
====================
Seven/CD
SNP/NN
sets/NNS
are/VBP
summarized/VBN
in/IN
Table/JJ
2/CD
./.
====================
Step/JJ
1/CD
:/:
Variable/JJ
selection/NN
====================
Variable/JJ
selection/NN
in/IN
each/DT
SNP/NN
set/NN
was/VBD
performed/VBN
via/IN
5-fold/JJ
CV/NN
of/IN
the/DT
training/VBG
set/NN
./.
====================
Fig/NN
./.
====================
2/CD
shows/VBZ
the/DT
overlapping/VBG
number/NN
of/IN
selected/VBN
SNPs/NNS
by/IN
the/DT
variable/JJ
selection/NN
methods/NNS
./.
====================
In/IN
addition/NN
,/,
Table/JJ
3/CD
provides/VBZ
more/RBR
detailed/JJ
information/NN
./.
====================
Overall/RB
,/,
SLR/NN
selected/VBN
fewer/JJR
SNPs/NNS
than/IN
LASSO/NN
and/CC
EN/NN
./.
====================
All/DT
SNPs/NNS
were/VBD
selected/VBN
when/WRB
EN/NN
was/VBD
used/VBN
in/IN
ASIAN-100/NN
,/,
ASIAN-200/CD
,/,
and/CC
KOREAN-200/NN
./.
====================
Step/JJ
2/CD
:/:
Quantitative/JJ
prediction/NN
====================
We/PRP
made/VBD
quantitative/JJ
prediction/NN
models/NNS
based/VBN
on/IN
SLR/NN
,/,
LASSO/NN
,/,
and/CC
EN/NN
using/VBG
the/DT
entire/JJ
training/VBG
dataset/NN
./.
====================
Then/RB
,/,
the/DT
MSE/NN
was/VBD
calculated/VBN
by/IN
applying/VBG
the/DT
quantitative/JJ
prediction/NN
models/NNS
to/TO
the/DT
test/NN
dataset/NN
./.
====================
Table/JJ
4/CD
and/CC
Fig/NN
./.
====================
3/CD
show/VBP
the/DT
performance/NN
of/IN
each/DT
quantitative/JJ
prediction/NN
model/NN
in/IN
the/DT
test/NN
dataset/NN
./.
====================
The/DT
model/NN
using/VBG
only/RB
covariates/VBZ
yielded/VBD
an/DT
MSE/NN
value/NN
of/IN
10.24/CD
./.
====================
As/IN
can/MD
be/VB
seen/VBN
from/IN
Fig/NN
./.
====================
3/CD
,/,
the/DT
prediction/NN
model/NN
created/VBD
from/IN
Group/NN
5/CD
yielded/VBD
the/DT
smallest/JJS
MSE/NN
./.
====================
Fig/NN
./.
====================
4/CD
describes/VBZ
the/DT
comparison/NN
results/NNS
between/IN
the/DT
numbers/NNS
of/IN
SNPs/NNS
and/CC
MSEs/NNS
from/IN
the/DT
prediction/NN
models/NNS
using/VBG
SLR/NN
./.
====================
Among/IN
all/DT
sets/NNS
,/,
the/DT
case/NN
that/DT
used/VBN
LASSO/NN
to/TO
select/VB
variables/NNS
and/CC
SLR/NN
to/TO
create/VB
the/DT
model/NN
showed/VBD
the/DT
smallest/JJS
MSE/NN
value/NN
of/IN
9.64/CD
in/IN
ASIAN-100/NN
,/,
with/IN
51/CD
SNPs/NNS
./.
====================
Among/IN
the/DT
51/CD
SNPs/NNS
of/IN
LASSO-SLR/NN
with/IN
one/CD
set/NN
from/IN
ASIAN-100/NN
,/,
28/CD
SNPs/NNS
were/VBD
mapped/VBN
to/TO
genes/NNS
(/(
Table/JJ
5/CD
)/)
./.
====================
Some/DT
genes/NNS
,/,
such/JJ
as/IN
FTO/NN
,/,
GP2/NN
,/,
AKAP6/NN
,/,
ANKS1B/NN
,/,
ADCY3/NN
,/,
and/CC
ADCY8/NN
,/,
have/VBP
been/VBN
reported/VBN
to/TO
be/VB
associated/VBN
with/IN
BMI/NN
[/(
282930313233/CD
]/)
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
used/VBD
statistical/JJ
methods/NNS
(/(
SLR/NN
,/,
LASSO/NN
,/,
and/CC
EN/NN
)/)
to/TO
select/VB
variables/NNS
and/CC
build/JJ
quantitative/JJ
prediction/NN
models/NNS
./.
====================
Then/RB
,/,
we/PRP
compared/VBD
the/DT
performance/NN
of/IN
the/DT
quantitative/JJ
prediction/NN
models/NNS
by/IN
each/DT
SNP/NN
set/NN
(/(
ASIAN-100/NN
,/,
KOREAN-100/NN
,/,
ALL-200/CD
,/,
ASIAN-200/CD
,/,
KOREAN-200/CD
,/,
GWAS-ALL/NN
,/,
and/CC
GWAS-ASIAN/NN
)/)
./.
====================
As/IN
a/DT
result/NN
,/,
the/DT
performance/NN
of/IN
the/DT
prediction/NN
models/NNS
using/VBG
the/DT
GWAS/NN
catalog/NN
and/CC
KARE/NN
data/NNS
was/VBD
better/RBR
than/IN
that/DT
of/IN
the/DT
prediction/NN
models/NNS
using/VBG
only/RB
SNPs/NNS
reported/VBD
in/IN
the/DT
GWAS/NN
catalog/NN
./.
====================
For/IN
the/DT
case/NN
that/DT
selected/VBN
variants/NNS
using/VBG
LASSO/NN
in/IN
ASIAN-100/NN
and/CC
created/VBD
a/DT
prediction/NN
model/NN
using/VBG
SLR/NN
,/,
the/DT
MSE/NN
value/NN
was/VBD
the/DT
smallest/JJS
,/,
9.64/CD
./.
====================
At/IN
this/DT
time/NN
,/,
the/DT
number/NN
of/IN
SNPs/NNS
was/VBD
51/CD
./.
====================
Also/RB
,/,
for/IN
the/DT
model/NN
with/IN
the/DT
fewest/JJ
SNPs/NNS
,/,
we/PRP
selected/VBD
variables/NNS
using/VBG
SLR/NN
from/IN
ALL-200/CD
and/CC
created/VBD
a/DT
model/NN
using/VBG
SLR/NN
./.
====================
The/DT
number/NN
of/IN
SNPs/NNS
was/VBD
38/CD
,/,
and/CC
the/DT
MSE/NN
value/NN
was/VBD
9.84/CD
./.
====================
Through/IN
the/DT
5-fold/JJ
CV/NN
,/,
we/PRP
developed/VBD
a/DT
quantitative/JJ
prediction/NN
model/NN
./.
====================
After/IN
calculating/JJ
MSE/NN
from/IN
groups/NNS
1/CD
to/TO
5/CD
,/,
when/WRB
assembled/VBN
with/IN
SNPs/NNS
that/DT
were/VBD
included/VBN
in/IN
all/DT
CVs/NNS
,/,
the/DT
resulting/VBG
values/NNS
of/IN
MSE/NN
were/VBD
small/JJ
./.
====================
However/RB
,/,
when/WRB
a/DT
different/JJ
group/NN
was/VBD
used/VBN
,/,
the/DT
MSE/NN
value/NN
was/VBD
bigger/JJR
than/IN
when/WRB
using/VBG
the/DT
covariates/NNS
to/TO
build/JJ
the/DT
model/NN
./.
====================
Therefore/RB
,/,
with/IN
CV/NN
,/,
when/WRB
using/VBG
SNPs/NNS
that/DT
match/VBP
each/DT
of/IN
their/PRP$
CVs/NNS
,/,
the/DT
efficiency/NN
of/IN
their/PRP$
quantitative/JJ
prediction/NN
model/NN
was/VBD
high/JJ
./.
====================
In/IN
the/DT
variable/JJ
selection/NN
,/,
SLR/NN
performed/VBN
better/RBR
than/IN
other/JJ
methods/NNS
./.
====================
SLR/NN
selected/VBN
fewer/JJR
SNPs/NNS
than/IN
the/DT
other/JJ
methods/NNS
in/IN
all/DT
SNP/NN
sets/NNS
while/IN
providing/VBG
smaller/JJR
MSEs/NNS
./.
====================
It/PRP
seems/VBZ
that/DT
LASSO/NN
and/CC
EN/NN
tended/VBD
to/TO
select/VB
SNPs/NNS
with/IN
little/JJ
contribution/NN
to/TO
BMI/NN
./.
====================
For/IN
further/RBR
research/NN
,/,
we/PRP
plan/VBP
to/TO
perform/VB
simulation/JJ
studies/NNS
and/CC
a/DT
real-data/NN
analysis/NN
with/IN
other/JJ
continuous/JJ
traits/VBZ
./.
====================
There/EX
are/VBP
many/JJ
ways/NNS
to/TO
extend/VB
the/DT
analysis/NN
of/IN
quantitative/JJ
prediction/NN
studies/NNS
./.
====================
First/RB
,/,
along/IN
with/IN
the/DT
application/NN
of/IN
recently/RB
developed/VBD
methods/NNS
,/,
such/JJ
as/IN
bootstrapping/VBG
methods/NNS
[/(
3435/CD
]/)
,/,
we/PRP
will/MD
continue/VB
to/TO
explore/VB
new/JJ
ways/NNS
to/TO
develop/VB
more/RBR
prediction/NN
models/NNS
./.
====================
Second/RB
,/,
the/DT
incorporation/NN
of/IN
rare/JJ
variants/NNS
can/MD
improve/VB
the/DT
performance/NN
of/IN
a/DT
quantitative/JJ
prediction/NN
model/NN
./.
====================
Advanced/JJ
sequencing/NN
technology/NN
has/VBZ
made/VBN
it/PRP
possible/JJ
to/TO
investigate/VB
the/DT
role/NN
of/IN
common/JJ
and/CC
rare/JJ
variants/NNS
in/IN
complex/NN
disease/NN
risk/NN
prediction/NN
./.
====================
Additionally/RB
,/,
we/PRP
can/MD
use/VB
biological/JJ
information/NN
while/IN
choosing/NN
the/DT
variables/NNS
./.
====================
By/IN
using/VBG
single-SNP/JJ
analysis/NN
,/,
we/PRP
can/MD
use/VB
gene/NN
or/CC
pathway/NN
information/NN
to/TO
find/VB
useful/JJ
SNPs/NNS
[/(
36/CD
]/)
,/,
and/CC
from/IN
here/RB
,/,
we/PRP
can/MD
assemble/VB
an/DT
SNP/NN
set/NN
by/IN
adding/VBG
an/DT
SNP/NN
list/NN
from/IN
the/DT
pathways/NNS
related/JJ
to/TO
the/DT
disease/NN
of/IN
interest/JJ
./.
====================
Box/DT
plots/NNS
of/IN
body/NN
mass/NN
index/NN
(/(
BMI/NN
)/)
for/IN
the/DT
given/VBN
demographic/JJ
variables/NNS
./.
====================
Venn/RB
diagrams/NNS
give/VBP
us/PRP
shared/VBN
parts/NNS
from/IN
5-fold/JJ
CV/NN
by/IN
variables/NNS
selection/NN
methods/NNS
./.
====================
CV/RB
,/,
cross-validation/JJ
;/:
ASIAN-100/RB
,/,
genome-wide/RB
association/NN
study/RB
(/(
GWAS/NNP
)/)
catalog/NN
(/(
Asia/NN
)/)
+/CC
singlesingle-nucleotide/JJ
polymorphism/NN
(/(
SNP/NN
)/)
analysis/NN
;/:
KOREAN-100/NN
,/,
GWAS/NNP
catalog/NN
(/(
Korea/NN
)/)
+/CC
single-SNP/JJ
analysis/NN
;/:
ALL-200/RB
,/,
GWAS/NNP
catalog/NN
(/(
All/DT
)/)
+/CC
single-SNP/JJ
analysis/NN
;/:
ASIAN-200/RB
,/,
GWAS/NNP
catalog/NN
(/(
Asia/NN
)/)
+/CC
single-SNP/JJ
analysis/NN
;/:
KOREAN-200/CD
,/,
GWAS/NNP
catalog/NN
(/(
Korea/NN
)/)
+/CC
single-SNP/JJ
analysis/NN
;/:
GWAS-ALL/NN
,/,
GWAS/NNP
catalog/NN
(/(
All/DT
)/)
;/:
GWAS-ASIAN/NNP
,/,
GWAS/NNP
catalog/NN
(/(
Asia/NN
)/)
;/:
SLR/NNP
,/,
stepwise/RB
linear/JJ
regression/NN
;/:
LASSO/NNP
,/,
least/JJS
absolute/RB
shrinkage/RB
and/CC
selection/NN
operator/NN
;/:
EN/NNP
,/,
Elastic-Net/NNP
./.
====================
Each/DT
set/NN
by/IN
MSE/NN
value/NN
,/,
x-axis/NN
are/VBP
the/DT
number/NN
of/IN
CV/NN
containing/VBG
the/DT
selected/VBN
variable/JJ
./.
====================
Group/NN
1/CD
,/,
5/CD
is/VBZ
a/DT
model/NN
from/IN
variables/NNS
of/IN
the/DT
union/NN
of/IN
CV/NN
and/CC
of/IN
the/DT
intersection/NN
of/IN
CV/NN
,/,
respectively/RB
./.
====================
The/DT
gray/JJ
bar/JJ
indicates/VBZ
the/DT
SLR/NN
,/,
the/DT
orange/NN
bar/JJ
indicates/VBZ
the/DT
LASSO/NN
,/,
the/DT
blue/JJ
bar/JJ
indicates/VBZ
the/DT
EN/NN
and/CC
the/DT
black/JJ
line/NN
is/VBZ
MSE/NN
value/NN
of/IN
10.24/CD
from/IN
the/DT
prediction/NN
model/NN
using/VBG
only/RB
covariates/VBZ
./.
====================
MSE/DT
,/,
mean/JJ
square/RB
error/CC
;/:
CV/NNP
,/,
cross-validation/JJ
;/:
ASIAN-100/RB
,/,
genome-wide/RB
association/NN
study/RB
(/(
GWAS/NNP
)/)
catalog/NN
(/(
Asia/NNP
)/)
+/CC
single-single-nucleotide/JJ
polymorphism/NN
(/(
SNP/NN
)/)
analysis/NN
;/:
KOREAN-100/NN
,/,
GWAS/NNP
catalog/NN
(/(
Korea/NN
)/)
+/CC
single-SNP/JJ
analysis/NN
;/:
ALL-200/RB
,/,
GWAS/NNP
catalog/NN
(/(
All/DT
)/)
+/CC
single-SNP/JJ
analysis/NN
;/:
ASIAN-200/RB
,/,
GWAS/NNP
catalog/NN
(/(
Asia/NNP
)/)
+/CC
single-SNP/JJ
analysis/NN
;/:
KOREAN-200/CD
,/,
GWAS/NNP
catalog/NN
(/(
Korea/NN
)/)
+/CC
single-SNP/JJ
analysis/NN
;/:
GWAS-ALL/NNP
,/,
GWAS/NNP
catalog/NN
(/(
All/DT
)/)
;/:
GWAS-ASIAN/NNP
,/,
GWAS/NNP
catalog/NN
(/(
Asia/NNP
)/)
;/:
SLR/NNP
,/,
stepwise/RB
linear/JJ
regression/NN
;/:
LASSO/NNP
,/,
least/JJS
absolute/RB
shrinkage/RB
and/CC
selection/NN
operator/NN
;/:
EN/NNP
,/,
Elastic-Net/NNP
./.
====================
The/DT
comparison/NN
of/IN
the/DT
results/NNS
from/IN
variables/NNS
selected/VBN
by/IN
different/JJ
methods/NNS
and/CC
from/IN
creating/VBG
a/DT
model/NN
using/VBG
stepwise/JJ
./.
====================
MSE/DT
,/,
mean/JJ
square/RB
error/CC
;/:
SNP/NN
,/,
single-nucleotide/JJ
polymorphism/NN
;/:
ASIAN-100/RB
,/,
genome-wide/RB
association/NN
study/RB
(/(
GWAS/NNP
)/)
catalog/NN
(/(
Asia/NN
)/)
+/CC
single-SNP/JJ
analysis/NN
;/:
KOREAN-100/NN
,/,
GWAS/NNP
catalog/NN
(/(
Korea/NN
)/)
+/CC
single-SNP/JJ
analysis/NN
;/:
ALL-200/RB
,/,
GWAS/NNP
catalog/NN
(/(
All/DT
)/)
+/CC
single-SNP/JJ
analysis/NN
;/:
ASIAN-200/RB
,/,
GWAS/NNP
catalog/NN
(/(
Asia/NN
)/)
+/CC
single-SNP/JJ
analysis/NN
;/:
KOREAN-200/CD
,/,
GWAS/NNP
catalog/NN
(/(
Korea/NN
)/)
+/CC
single-SNP/JJ
analysis/NN
;/:
GWAS-ALL/NN
,/,
GWAS/NNP
catalog/NN
(/(
All/DT
)/)
;/:
GWAS-ASIAN/NNP
,/,
GWAS/NNP
catalog/NN
(/(
Asia/NN
)/)
;/:
SLR/NNP
,/,
stepwise/RB
linear/JJ
regression/NN
;/:
LASSO/NNP
,/,
least/JJS
absolute/RB
shrinkage/RB
and/CC
selection/NN
operator/NN
;/:
EN/NNP
,/,
Elastic-Net/NNP
./.
====================
Demographic/JJ
variables/NNS
for/IN
KARE/NN
cohort/NN
====================
List/NN
of/IN
the/DT
SNP/NN
sets/NNS
====================
The/DT
number/NN
of/IN
overlapping/VBG
SNPs/NNS
selected/VBN
by/IN
5-fold/JJ
CV/NN
for/IN
each/DT
variable/JJ
selection/NN
method/NN
====================
MSE/NN
values/NNS
from/IN
test/NN
dataset/NN
====================
Development/NN
of/IN
LASSO-SLR/NN
prediction/NN
model/NN
with/IN
one/CD
set/NN
from/IN
ASIAN-100/NN
for/IN
predicting/VBG
BMI/NN
====================
